CIK: 1808509 - Address: C/O Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston, MA 02110
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/12/24 16:05
3/8/24
IRWDIronwood Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShetzline MichaelMAOCMO,SVP,M.d00.000359430D
2/14/24 20:53
2/12/24
IRWDIronwood Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShetzline MichaelMAOCMO,SVP,S.d-58915.240-39-9395D
5/24/23 16:05
5/22/23
IRWDIronwood Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShetzline MichaelMAOCMO,SVP,S-10410.120-10-3321D
3/1/23 18:21
2/27/23
IRWDIronwood Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShetzline MichaelMAOCMO,SVP,S.m-21911.360-19-7262D
5/25/22 16:05
5/23/22
IRWDIronwood Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShetzline MichaelMAOCMO,SVP,S-12211.500-11-4266D
3/2/22 16:01
2/28/22
IRWDIronwood Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShetzline MichaelMAOCMO,SVP,S-19010.770-18-8195D
11/24/21 16:08
11/23/21
IRWDIronwood Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShetzline MichaelMAOCMO,SVP,S-16011.580-14-7184D
5/26/21 16:05
5/24/21
IRWDIronwood Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShetzline MichaelMAOCMO,SVP,S-2512.250-2-1197D
3/2/21 16:44
2/26/21
IRWDIronwood Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShetzline MichaelMAOCMO,SVP,S-409.110-4-3161D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact